GlassScriptPhysician profile
Erik Kuecher
NPI 1578956827
$1,239.45
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $582.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $350.07 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $158.02 | 2021-2022 | |
| Kyowa Kirin, INC. | $96.78 | 2021 | |
| Biogen, INC. | $64.58 | 2021 | |
| Neurocrine Biosciences, INC. | $51.69 | 2021 | |
| Csl Behring | $50.51 | 2021-2022 | |
| Avanir Pharmaceuticals, INC. | $45.24 | 2022 | |
| Allergan, INC. | $37.11 | 2021 | |
| Amneal Pharmaceuticals LLC | $34.48 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $33.58 | 2021 | |
| Eisai INC. | $30.70 | 2022 | |
| Merz Pharmaceuticals, LLC | $29.30 | 2022 | |
| Supernus Pharmaceuticals, INC. | $29.08 | 2022 | |
| Genentech USA, INC. | $26.91 | 2022 | |
| Insightec,INC | $26.46 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $26.05 | 2022 | |
| Acadia Pharmaceuticals INC | $24.53 | 2021 | |
| Lilly USA, LLC | $23.26 | 2022 | |
| Banner Life Sciences, LLC | $22.59 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.14 | 2022 | |
| Sunovion Pharmaceuticals INC. | $21.25 | 2021 | |
| Acorda Therapeutics, INC | $19.84 | 2022 | |
| Impel Pharmaceuticals INC. | $15.28 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Kuecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.